Cited by 41ECG Monitoring and AnalysisCardiomyopathy and Myosin StudiesCardiac electrophysiology and arrhythmias

Identification of hypertrophic cardiomyopathy on electrocardiographic images with deep learning

Open access
Sangha, Veer, Dhingra, Lovedeep Singh, Aminorroaya, Arya, Croon, Philip M., Sikand, Nikhil V., Sen, Sounok, Martinez, Matthew W., Maron, Martin S. +4 more·2025·Nature Cardiovascular Research

Published version of a preprint

Abstract

Hypertrophic cardiomyopathy (HCM) is frequently underdiagnosed. Although deep learning (DL) models using raw electrocardiographic (ECG) voltage data can enhance detection, their use at the point of care is limited. Here we report the development and validation of a DL model that detects HCM from images of 12-lead ECGs across layouts. The model was developed using 124,553 ECGs from 66,987 individuals at the Yale New Haven Hospital (YNHH), with HCM features determined by concurrent imaging (cardiac magnetic resonance (CMR) or echocardiography). External validation included ECG images from MIMIC-IV, the Amsterdam University Medical Center (AUMC) and the UK Biobank (UKB), where HCM was defined by CMR (YNHH, MIMIC-IV and AUMC) and diagnosis codes (UKB). The model demonstrated robust performance across image formats and sites (areas under the receiver operating characteristic curve (AUROCs): 0.95 internal testing; 0.94 MIMIC-IV; 0.92 AUMC; 0.91 UKB). Discriminative features localized to anterior/lateral leads (V4 and V5) regardless of layout. This approach enables scalable, image-based screening for HCM across clinical settings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s44161-025-00685-3

Cites

48 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypertrophic cardiomyopathy, cardiac amyloidosis, and pulmonary hypertension AI-ECG applications remain earlier or pathway-incomplete.

    “hypertrophic cardiomyopathy, cardiac amyloidosis, and pulmonary hypertension remain earlier or pathway-incomplete applications.”

    From AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions (2026) · cites this paper as [29]

    The Discussion (page unavailable) says the HCM AI-ECG model needs prospective validation before widespread screening deployment and that a role for universal screening remains to be established. This supports describing the HCM application as pathway-incomplete. The paper does not address the development or implementation status of AI-ECG applications for cardiac amyloidosis or pulmonary hypertension. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Sangha et al. reported that a deep-learning model operating on ECG images detected HCM with AUROCs of 0.95 in the internal test set and 0.94, 0.92, and 0.91 across three external datasets.

    “More recently, Sangha et al reported in a peer-reviewed study that a deep-learning model operating on ECG images—not raw waveform files—detected HCM with AUROCs of 0.95 in the internal test set and 0.94, 0.92, and 0.91 across three external datasets, supporting a potentially more deployable image-based screening route.29”

    From AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions (2026) · cites this paper as [29]

    The Detection of HCM section reports an AUROC of 0.96 for the held-out internal test set, although it gives a range of 0.95–0.96 across ECG layouts. External Validation reports an AUROC of 0.94 for UK Biobank images; our copy does not report three external datasets with AUROCs of 0.94, 0.92, and 0.91. The paper does support the claim that the model detects HCM from ECG images. (LLM, conf=0.91)

    Experimental — accuracy not yet measured
  • HCM and cardiac amyloidosis should be regarded as clinically important but pathway-incomplete domains rather than deployable screening indications comparable to low-LVEF AI-ECG.

    “Taken together, HCM and CA should therefore be regarded as clinically important but pathway-incomplete domains rather than deployable screening indications comparable to low-LVEF AI-ECG.26–30,43”

    From AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions (2026) · cites this paper as [29]

    The Discussion (page unavailable) says prospective validation is needed before widespread HCM screening deployment and that the role of universal screening remains to be established. This supports the HCM portion of the claim. The paper does not address cardiac amyloidosis or compare HCM screening with low-LVEF AI-ECG, so it does not support the full sentence attributed to the citation group. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Maron BJ. Hypertrophic cardiomyopathy. JAMA. 2002;287:1308-1320.
  2. Canepa M, Fumagalli C, Tini G, Vincent-Tompkins J, Day SM, Ashley EA, Mazzarotto F, Ware JS, Michels M, Jacoby D, Ho CY, Olivotto I, The SHaRe Investigators. Temporal trend of age at diagnosis in hypertrophic cardiomyopathy. Circ Heart Fail [Internet]. 2020;13. Available from: http://dx.doi.org/10.1161/circheartfailure.120.007230 · DOI

Cited by

Sorted by citations

Authors
Sangha, V., Dhingra, L. S., Aminorroaya, A., Croon, P. M., Sikand, N. V., Sen, S., Martinez, M. W., Maron, M. S., Krumholz, H. M., Asselbergs, F. W., Oikonomou, E. K., & Khera, R.
Affiliations
  • Yale University (US)
  • Amsterdam University Medical Centers (NL)
  • Morristown Medical Center (US)
  • Tufts Medical Center (US)
  • Yale New Haven Hospital (US)
  • National Institute for Health and Care Research (GB)
Corresponding author
Khera, Rohan
Venue
Nature Cardiovascular Research
Published
2025-07-22
Volume
4
Issue
8
Pages
991-1000
ISSN
2731-0590 (ISSN-L)
OpenAlex
W4412552358
Cited by
41
References
48
Citations by year
2026: 16 · 2025: 14 · 2024: 11
FWCI
20.96
Type
journal article
Language
en
Open access
Locations
  • Nature Cardiovascular Research (publishedVersion)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • UCL Discovery (University College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K23HL153775, R01HL167858, 1F32HL170592-01)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
hypertrophic cardiomyopathy, electrocardiogram, 12-lead ECG, deep learning, automated disease detection, cardiac magnetic resonance, echocardiography, external validation, MIMIC-IV, UK Biobank

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review